0001437749-23-032191.txt : 20231115
0001437749-23-032191.hdr.sgml : 20231115
20231115170355
ACCESSION NUMBER: 0001437749-23-032191
CONFORMED SUBMISSION TYPE: 4/A
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20231115
FILED AS OF DATE: 20231115
DATE AS OF CHANGE: 20231115
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Finn Jonathan
CENTRAL INDEX KEY: 0001981595
FILING VALUES:
FORM TYPE: 4/A
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-35610
FILM NUMBER: 231411408
MAIL ADDRESS:
STREET 1: C/O VANTAGE CONSULTING GROUP, INC.
STREET 2: 3500 PACIFIC AVENUE
CITY: VIRGINIA BEACH
STATE: VA
ZIP: 23451
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: ATOSSA THERAPEUTICS, INC.
CENTRAL INDEX KEY: 0001488039
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 264753208
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 107 SPRING STREET
CITY: SEATTLE
STATE: WA
ZIP: 98104
BUSINESS PHONE: 206.588.0256
MAIL ADDRESS:
STREET 1: 107 SPRING STREET
CITY: SEATTLE
STATE: WA
ZIP: 98104
FORMER COMPANY:
FORMER CONFORMED NAME: ATOSSA GENETICS INC
DATE OF NAME CHANGE: 20100325
4/A
1
rdgdoc.xml
FORM 4/A
X0508
4/A
2023-11-15
2023-11-15
0001488039
ATOSSA THERAPEUTICS, INC.
ATOS
0001981595
Finn Jonathan
C/O ATOSSA THERAPEUTICS, INC.
107 SPRING STREET
SEATTLE
WA
98104
1
0
Stock Option (right to buy)
0.65
2023-11-15
4
A
0
62500
0
A
2033-11-15
Common Stock
62500
62500
D
The options shall vest in four equal quarterly installments following November 15, 2023.
/s/ Heather Rees, as attorney-in-fact for Jonathan Finn
2023-11-15